Furthermore, direct inhibition of VEGF or Flk-1 signaling (with neutralizing antibodies or receptor tyrosine kinase inhibitor) could also attenuate DN in both mouse and rat models [14-16]. This evidence concerns the gene KDR and liver dysplastic nodule.